TY - JOUR T1 - Ber-EP4 staining in effusion cytology: A potential source of false positives JO - Revista Española de Patología T2 - AU - Díaz del Arco,Cristina AU - Saiz-Pardo Sanz,Melchor AU - Ortega Medina,Luis AU - Fernández Aceñero,Mª Jesús SN - 16998855 M3 - 10.1016/j.patol.2020.04.005 DO - 10.1016/j.patol.2020.04.005 UR - https://www.elsevier.es/es-revista-revista-espanola-patologia-297-articulo-ber-ep4-staining-in-effusion-cytology-S1699885520300556 AB - The distinction between reactive mesothelium and carcinoma in serous effusions can be very difficult. Immunocytochemistry (ICC) is the most widely used tool to improve the diagnostic accuracy of body fluid cytology, with several ICC markers being proposed. Ber-EP4 antibody has shown high sensitivity and specificity rates for diagnosing metastatic carcinoma. In our department, we have detected Ber-EP4 positivity in mesothelium in some cytological specimens. We reviewed all articles on Ber-EP4 staining in effusion cytology, summarized current findings and analyzed the staining pattern of all cases expressing Ber-EP4. Some cases showing Ber-EP4 positivity in mesothelium have been reported, most of which showed only weak Ber-EP4 staining or staining of less than 50% of mesothelial cells. However, some cases may show strong positivity both in cytological and histological specimens. Clinicians and pathologists should be aware of this source of misdiagnosis, and ICC results in mesothelium should be always interpreted cautiously and correlated with clinical tests, other ICC markers and patient's previous history. ER -